- Teede H.J.
- Misso M.L.
- Deeks A.A.
- et al.
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.
Med J Aust. 2011; 195: S65-S112- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Fertil Steril. 2004; 81: 19-25- Norman R.J.
- Dewailly D.
- Legro R.S.
- et al.
Polycystic ovary syndrome.
Lancet. 2007; 370: 685-697- Cesta C.E.
- Månsson M.
- Palm C.
- et al.
Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.
Psychoneuroendocrinology. 2016; 73: 196-203- Brutocao C.
- Zaiem F.
- Alsawas M.
- et al.
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Endocrine. 2018; 62: 318-325- Dokras A.
- Stener-Victorin E.
- Yildiz B.O.
- et al.
Androgen excess- polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome.
Fertil Steril. 2018; 109: 888-899- Dokras A.
- Saini S.
- Gibson-Helm M.
- et al.
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome.
Fertil Steril. 2017; 107: 1380-1386.e1Persistent risk: psychological comorbidity in polycystic ovary syndrome.
Endocrinology&Metabolism International Journal. 2020; 8: 139-141- Thannickal A.
- Brutocao C.
- Alsawas M.
- et al.
Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.
Clin Endocrinol (Oxf). 2020; https://doi.org/10.1111/cen.14153- Alur-Gupta S.
- Lee I.
- Chemerinski A.
- et al.
Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome.
F S Rep. 2021; 2: 230-237- Elsenbruch S.
- Hahn S.
- Kowalsky D.
- et al.
Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 2003; 88: 5801-5807- Karjula S.
- Morin-Papunen L.
- Franks S.
- et al.
Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms.
J Clin Endocrinol Metab. 2020; 105: 1814-1826- Standeven L.R.
- Olson E.
- Leistikow N.
- et al.
Polycystic ovary syndrome, affective symptoms, and neuroactive steroids: a focus on allopregnanolone.
Curr Psychiatry Rep. 2021; 23: 36- Cooney L.G.
- Lee I.
- Sammel M.D.
- et al.
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Hum Reprod. 2017; 32: 1075-1091- Kerchner A.
- Lester W.
- Stuart S.P.
- et al.
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.
Fertil Steril. 2009; 91: 207-212- Hung J.H.
- Hu L.Y.
- Tsai S.J.
- et al.
Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study.
PLoS One. 2014; 9: e97041- Cinar N.
- Kizilarslanoglu M.C.
- Harmanci A.
- et al.
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome.
Hum Reprod. 2011; 26: 3339-3345- Hollinrake E.
- Abreu A.
- Maifeld M.
- et al.
Increased risk of depressive disorders in women with polycystic ovary syndrome.
Fertil Steril. 2007; 87: 1369-1376- Månsson M.
- Holte J.
- Landin-Wilhelmsen K.
- et al.
Women with polycystic ovary syndrome are often depressed or anxious—A case control study.
Psychoneuroendocrinology. 2008; 33: 1132-1138Depression and anxiety in polycystic ovary syndrome: etiology and treatment.
Curr Psychiatry Rep. 2017; 19: 83- Jedel E.
- Waern M.
- Gustafson D.
- et al.
Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index.
Human Reproduction (Oxford, England). 2010; 25: 450-456- Barry J.A.
- Hardiman P.J.
- Saxby B.K.
- et al.
Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls.
J Psychosom Obstet Gynaecol. 2011; 32: 104-111- Annagur B.B.
- Tazegul A.
- Akbaba N.
Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome.
Noro Psikiyatr Ars. 2014; 51: 129-132- Himelein M.J.
- Thatcher S.S.
Depression and body image among women with polycystic ovary syndrome.
J Health Psychol. 2006; 11: 613-625- Karacan E.
- Caglar G.S.
- Gürsoy A.Y.
- et al.
Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome.
J Pediatr Adolesc Gynecol. 2014; 27: 72-77- Moran L.J.
- Noakes M.
- Clifton P.M.
- et al.
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome.
Am J Clin Nutr. 2007; 86: 1603-1610- Lee I.
- Cooney L.G.
- Saini S.
- et al.
Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis.
Eat Weight Disord. 2019; 24: 787-797- Jensterle M.
- Kocjan T.
- Kravos N.A.
- et al.
Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
Endocr Res. 2015; 40: 133-138- Lin T.-Y.
- Lin P.-Y.
- Su T.-P.
- et al.
Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome: a nationwide longitudinal follow-up study.
Sleep Med. 2017; 36: 165-169- Fernandez R.C.
- Moore V.M.
- Van Ryswyk E.M.
- et al.
Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.
Nat Sci Sleep. 2018; 10: 45-64- Williams S.
- Fido D.
- Sheffield D.
Polycystic ovary syndrome (PCOS) and non-suicidal self-injury (NSSI): a community-based study.
Healthcare (Basel). 2022; 10: 1118- Hoeger K.M.
- Dokras A.
- Piltonen T.
Update on PCOS: Consequences, Challenges, and Guiding Treatment.
J Clin Endocrinol Metab. 2021; 106: e1071-e1083- Hsiao M.-C.
- Hsiao C.-C.
- Liu C.-Y.
Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders.
Psychiatr Clin Neurosci. 2004; 58: 186-190- Goodman N.F.
- Cobin R.H.
- Futterweit W.
- et al.
American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 1.
Endocr Pract. 2015; 21: 1291-1300- AlHussain F.
- AlRuthia Y.
- Al-Mandeel H.
- et al.
Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program.
Patient Prefer Adherence. 2020; 14: 737-746- Moiz A.
- Mohammad I.
- Shehroz K.
Effects of metformin on symptoms of polycystic ovarian syndrome among women of reproductive age.
Cureus. 2018; 10: e3203- Hahn S.
- Janssen O.E.
- Tan S.
- et al.
Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.
Eur J Endocrinol. 2005; 153: 853-860- Altinok M.L.
- Ravn P.
- Andersen M.
- et al.
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Gynecol Endocrinol. 2018; 34: 859-863- Kurzthaler D.
- Hadziomerovic-Pekic D.
- Wildt L.
- et al.
Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects.
Reprod Biol Endocrinol. 2014; 12: 98- Barry J.A.
- Qu F.
- Hardiman P.J.
An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS).
Med Hypotheses. 2018; 110: 42-45- Maharjan D.T.
- Syed A.A.S.
- Lin G.N.
- et al.
testosterone in female depression: a meta-analysis and mendelian randomization study.
Biomolecules. 2021; 11: 409- Ethirajulu A.
- Alkasabera A.
- Onyali C.B.
- et al.
Insulin resistance, hyperandrogenism, and its associated symptoms are the precipitating factors for depression in women with polycystic ovarian syndrome.
Cureus. 2021; 13: e18013- Lawlor D.A.
- Smith G.D.
- Ebrahim S.
- British Women’s Heart
- Health Study
Association of insulin resistance with depression: cross sectional findings from the British Women’s Heart and Health Study.
BMJ. 2003; 327: 1383-1384- Weiner C.L.
- Primeau M.
- Ehrmann D.A.
Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls.
Psychosom Med. 2004; 66: 356-362- Jedel E.
- Gustafson D.
- Waern M.
- et al.
Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
Psychoneuroendocrinology. 2011; 36: 1470-1479- Hahn S.
- Benson S.
- Elsenbruch S.
- et al.
Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality.
Hum Reprod. 2006; 21: 1925-1934- Erensoy H.
- Niafar M.
- Ghafarzadeh S.
- et al.
A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.
Gynecol Endocrinol. 2019; 35: 72-75- Kashani L.
- Omidvar T.
- Farazmand B.
- et al.
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
Psychoneuroendocrinology. 2013; 38: 767-776- Guo Q.-J.
- Shan J.
- Xu Y.-F.
- et al.
Pioglitazone metformin complex improves polycystic ovary syndrome comorbid psychological distress via inhibiting NLRP3 inflammasome activation: a prospective clinical study.
Mediators Inflamm. 2020; 2020: 3050487Endocrine risk factors of endometrial cancer: polycystic ovary syndrome, oral contraceptives, infertility.
Tamoxifen. Cancers (Basel). 2020; 12: 1766- Standeven L.R.
- McEvoy K.O.
- Osborne L.M.
Progesterone, reproduction, and psychiatric illness.
Best Pract Res Clin Obstet Gynaecol. 2020; 69: 108-126Premenstrual dysphoric disorder: epidemiology and treatment.
Curr Psychiatry Rep. 2015; 17: 87- Masoudi M.
- Ansari S.
- Kashani L.
- et al.
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial.
Int Clin Psychopharmacol. 2021; 36: 238-243- Cooney L.G.
- Milman L.W.
- Hantsoo L.
- et al.
Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial.
Fertil Steril. 2018; 110: 161-171.e1- Abdollahi L.
- Mirghafourvand M.
- Babapour J.K.
- et al.
Effectiveness of cognitive-behavioral therapy (CBT) in improving the quality of life and psychological fatigue in women with polycystic ovarian syndrome: a randomized controlled clinical trial.
J Psychosom Obstet Gynecol. 2019; 40: 283-293- Jiskoot G.
- van der Kooi A.-L.
- Busschbach J.
- et al.
Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis.
Reprod Biomed Online. 2022; 45: 599-607- Tang R.
- Yang J.
- Yu Y.
- et al.
The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: A meta-analysis.
Front Psychol. 2022; 13: 796594- Stefanaki C.
- Bacopoulou F.
- Livadas S.
- et al.
Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial.
Stress. 2015; 18: 57-66- Karabacak I.Y.N.I.
- Karabacak O.
- Törüner F.B.
- et al.
Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease.
Gynecol Endocrinol. 2004; 19: 196-201